Figure 2: Alterations in DC, B and γδ1 T cell phenotypes in control, moderate and severe CFS/ME participant groups. (A) DC phenotypes, including pDs, mDCs and CD14-CD16+ DCs where data is represented as the total number of cells (cells/μL). (B) B cell phenotypes (memory, plasma, naive, transitional and regulatory B cells) in control, moderate and severe CFS/ME groups represented as total number of cells (cells/μL). (C) γδ1 T cell CD45RA+CD27- and CD45RA+CD27+ phenotypes are represented as total number of cells (cells/μL). (D) γδ1 T cell phenotypes CD45RA-CD27- and CD45RA-CD27+ are represented as total number of cells (cells/μL). Data are represented as mean ± SEM. *represents results that were significantly different where p < 0.05. DC: Dendritic Cell; CFS/ME: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis; pDC: Plasmacytoid Dendritic Cell; mDC: Myeloid Dendritic Cells; SEM: Standard Error of the Mean.